key: cord-0847232-xzv82pyt
authors: Haage, V. C.; Moreira-Soto, A.; Sacks, J. A.; Corman, V. M.; Drosten, C.; Drexler, J. F.
title: Limited specificity of SARS-CoV-2 antigen-detecting rapid diagnostic tests at low temperatures
date: 2021-02-03
journal: nan
DOI: 10.1101/2021.02.01.21250904
sha: c76026efc93d1b5b5f5c9a38f4f9fa0a75c5e508
doc_id: 847232
cord_uid: xzv82pyt

SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) are available within and outside of health care settings to enable increased access to COVID-19 diagnosis. These environments include provisional testing facilities, lacking temperature control; as outside temperatures fall, recommended testing temperatures cannot be guaranteed. We report impaired specificity in two out of six Ag-RDTs when used at 2-4{degrees}C, indicating that testing in cold settings might cause false-positive results potentially entailing unwarranted quarantine assignments and incorrect incidence estimates.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.01.21250904 doi: medRxiv preprint 3 the national COVID-19 reference laboratory in Germany, we were contacted by 53 physicians from two German metropolis both reporting an unusual high number of 54 positive SARS-CoV-2 Ag-RDTs from outside testing facilities. To test whether 55 operation of SARS-CoV-2 Ag-RDTs at low outside temperatures impacts their 56 performance, we selected six (Table 1) Figure 1A) . 66 Analytical specificity was examined by testing for cross-reactivity with common cell 67 culture-derived respiratory viruses including the ubiquitous human coronaviruses 68 (HCoV) HCoV-229E (2.9x10 7 copies/ml), HCoV-OC43 (1.0x10 6 copies/ml), influenza 69 virus A H1N1 (7.8x10 6 copies/ml) and rhinovirus A (2.2x10 6 copies/ml). Concentrations is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.01.21250904 doi: medRxiv preprint without symptoms of respiratory tract infection and tested negative for SARS-CoV-2 79 by RT-qPCR (10). All subjects received instructions on self-sampling, swabs were 80 immediately dissolved in 1ml PBS and 20µl of PBS were added to proprietary buffer 81 for testing. In a recent study, self-sampling was shown to be a reliable alternative to 82 professional nasopharyngeal swabs for Ag-RDTs (11).

Two of the six SARS-CoV-2 Ag-RDTs showed impaired specificity ( Figure 1B) when 86 stored at room temperature, but exposed to 2-4°C for 30 minutes prior to testing at 2- is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 3, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 3, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 3, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 3, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.01.21250904 doi: medRxiv preprint

Drive-190 Through Testing: A Unique, Efficient Method of Collecting Large Volume of Specimens During 191 the SARS-CoV-2 (COVID-19) Pandemic

Comparison of seven commercial SARS-CoV-2 rapid Point-of-Care Antigen tests

Detection of 2019 novel coronavirus (2019-nCoV) by real-207 time RT-PCR

Head-to-head comparison of SARS-CoV-2 antigen-211 detecting rapid test with self-collected anterior nasal swab versus professional-collected 212 nasopharyngeal swab

Impaired performance of SARS-CoV-2 antigen-218 detecting rapid tests at elevated temperatures. medRxiv 219

Variable sensitivity in molecular detection 222 of SARS-CoV-2 in European Expert Laboratories: External Quality Assessment

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.01.21250904 doi: medRxiv preprint